SHL Telemedicine secures long-term loan Dienstag, 14. März 2017 - 17:35

Press release

SHL Telemedicine secures long-term loan

Tel Aviv/Zurich, 14 March 2017 – SHL Telemedicine Ltd. (SIX Swiss Exchange: SHLTN, OTCPK: SMDCY), a leading provider and developer of advanced personal telemedicine solutions, today announced that it has signed a long-term loan agreement with a certain Israeli financial institution in an aggregate amount of NIS 100 million (approx. USD 27 million). Part of the proceeds shall be used to pre-pay SHL’s current loan in the amount of NIS 21 million thus increasing its net credit line by NIS 79 million.

Closing of the deal is subject to SHL registering certain pledges in favour of lenders.

Ehud Ben-Yair, CFO of SHL, noted: "By this deal the financial community sends another proof of confidence to SHL's ongoing business and future strategy. SHL is in a process of optimizing its financial resources and strengthening its relationship with financial institutions both in Israel and overseas. This deal is a major step which will enable the company to meet all its financial needs in the following years and reduce the effective cost of debt".

For further information, please contact:

Martin Meier-Pfister, IRF Communications, phone : +41 43 244 81 40, shl@irfcom.ch

Ehud Ben-Yair, CFO, ehudb@shl-telemedicine.com

About SHL Telemedicine

SHL Telemedicine is engaged in developing and marketing personal telemedicine systems and the provision of medical call center services, with a focus on cardiovascular and related diseases, to end users and to the healthcare community. SHL Telemedicine offers its services and personal telemedicine devices to subscribers utilizing telephonic and Internet communication technology. SHL is listed on the SIX Swiss Exchange (SHLTN, ISIN: IL0010855885, Security No.: 1128957) and has an ADR program listed over-the counter; Symbol: SMDCY. For more information, please visit the web site at www.shl-telemedicine.com.

Some of the information contained in this press release contains forward-looking statements. Readers are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those in the forward-looking statements as a result of various factors. SHL Telemedicine undertakes no obligation to publicly update or revise any forward-looking statements.